Profile
Christopher J.
DeRespino worked as an Executive Director of Business Development at Amgen, Inc. from 2018 to 2021.
Prior to that, he worked as a Director of Business Development at Onyx Pharmaceuticals, Inc. He also briefly served as the Chief Financial, Accounting & Business Officer at Adverum Biotechnologies, Inc. in 2021.
DeRespino received his undergraduate degree from The Johns Hopkins University and his MBA from The Leonard N Stern School of Business.
Former positions of Christopher J. DeRespino
| Companies | Position | End |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Director of Finance/CFO | 27/08/2021 |
| AMGEN INC. | Corporate Officer/Principal | 01/02/2021 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | - |
Training of Christopher J. DeRespino
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Christopher J. DeRespino
















